Literature DB >> 2458550

Contribution to the problem of giant cell astrocytomas.

W Müller1, F Slowik, R Firsching, D Afra, P Sanker.   

Abstract

Histological, immunocytochemical, and biological features of 38 giant cell gliomas were investigated. The invasion of these tumors and its giant cells by histiocytes, lymphocytes, plasma cells, and especially by eosinophilic granulocytes is viewed as an immune response, which may explain a favorable clinical course. Fifty-three percent of the patients were younger than 45 years at the time of surgery. The average postoperative survival of 27.4 months was clearly longer than in glioblastoma. These biological features suggest a differentiation from glioblastoma multiforme. The classification of this entity as "monstrocellular astrocytoma" is proposed.

Entities:  

Mesh:

Year:  1987        PMID: 2458550     DOI: 10.1007/bf01782050

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  36 in total

1.  [Cell proliferation and glial fibrillary acidic protein in brain tumors].

Authors:  J Kunz; J Gottschalk; W Jänisch; W Schulz
Journal:  Acta Histochem       Date:  1986       Impact factor: 2.479

2.  Cell membrane structure of human giant-celled glioblastoma.

Authors:  E Tani; M Nakano; T Itagaki; T Fukumori
Journal:  Acta Neuropathol       Date:  1978-01-19       Impact factor: 17.088

3.  Letter: Research, serendipity, and emperipolesis.

Authors:  H R Schumacher; I E Szekely; D R Fisher
Journal:  Lancet       Date:  1974-04-27       Impact factor: 79.321

4.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

5.  Histologic factors of prognostic significance in the glioblastoma multiforme.

Authors:  P C Burger; R T Vollmer
Journal:  Cancer       Date:  1980-09-01       Impact factor: 6.860

6.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.

Authors:  M S Peters; M Rodriguez; G J Gleich
Journal:  Lab Invest       Date:  1986-06       Impact factor: 5.662

8.  Monstrocellular heavily lipidized malignant glioma.

Authors:  R Gherardi; M Baudrimont; J P Nguyen; A Gaston; P Cesaro; J D Degos; J P Caron; J Poirier
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  A serially transplantable human giant cell glioblastoma that maintains a near-haploid stem line.

Authors:  S H Bigner; J Mark; S C Schold; L F Eng; D D Bigner
Journal:  Cancer Genet Cytogenet       Date:  1985-10

10.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

View more
  4 in total

1.  MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.

Authors:  John S Jarboe; Joshua C Anderson; Christine W Duarte; Tapan Mehta; Somaira Nowsheen; Patricia H Hicks; Alexander C Whitley; Timothy D Rohrbach; Raymond O McCubrey; Sherard Chiu; Tamara M Burleson; James A Bonner; G Yancey Gillespie; Eddy S Yang; Christopher D Willey
Journal:  Clin Cancer Res       Date:  2012-05-22       Impact factor: 12.531

2.  Molecular genetic analysis of giant cell glioblastomas.

Authors:  B Meyer-Puttlitz; Y Hayashi; A Waha; B Rollbrocker; J Boström; O D Wiestler; D N Louis; G Reifenberger; A von Deimling
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

3.  Replication of bovine herpesvirus type 4 in human cells in vitro.

Authors:  L Egyed
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

4.  Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Authors:  Takaya Tsuno; Atsushi Natsume; Shun Katsumata; Masaaki Mizuno; Mitsugu Fujita; Hirokatsu Osawa; Norimoto Nakahara; Toshihiko Wakabayashi; Yu-ichiro Satoh; Masaki Inagaki; Jun Yoshida
Journal:  J Neurooncol       Date:  2007-02-14       Impact factor: 4.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.